Heart Failure Mesenchymal Precursor Cells as Adjunctive Therapy in Recipients of Contemporary Left Ventricular Assist Devices Deborah D. Ascheim, MD; Annetine C. Gelijns, PhD; Daniel Goldstein, MD; Lemuel A. Moye, MD; Ni

First Page		Document Content
Date: 2014-06-25 19:11:29 Implants Interventional cardiology Prosthetics Cardiology Stem cells Ventricular assist device Destination therapy Thoratec LVAD Medicine Biology Health		Heart Failure Mesenchymal Precursor Cells as Adjunctive Therapy in Recipients of Contemporary Left Ventricular Assist Devices Deborah D. Ascheim, MD; Annetine C. Gelijns, PhD; Daniel Goldstein, MD; Lemuel A. Moye, MD; Ni Add to Reading List Source URL: www.mesoblast.com Download Document from Source Website File Size: 278,65 KB Share Document on Facebook

	Ethics, Law, and Policy Vicki D. Lachman Left Ventricular Assist Device DocID: 1oRq9 - View Document
	The Shared Care Advantage ™ For managing HeartMate II ® LVAD patients in the community DocID: 1m9lT - View Document
	Rapport LVAD werkgroep NVT / NVVC Aug 2014 Rapport DocID: 1buw2 - View Document
	Freeing the LVAD patient from drivelines using wireless resonant electrical transfer. Benjamin Waters, Alanson Sample, Joshua Smith, Pramod Bonde Background: Technological innovation of smaller, frictionless, single movi DocID: 17LmE - View Document
	Microsoft Word - ISHLT 35th Meeting and Scientific Sessions - ENDURANCE Destination Therapy Trial.docx DocID: 15vvQ - View Document